Matches in Nanopublications for { ?s ?p "[The SPINK1 N34S polymorphism was detected in 5 of 172 (2.9%) patients with chronic pancreatitis, in 4 of 200 (2.0%) patients with sporadic pancreatic adenocarcinoma, in 0 of 36 (0%) of patients with familial pancreatic cancer and in 3 of 177 (1.7%) controls of chronic cholecystitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP614554.RASFt-LB84fba1k8JlGOio9gAkR8ANUhqYxDAB07rCDbM130_assertion description "[The SPINK1 N34S polymorphism was detected in 5 of 172 (2.9%) patients with chronic pancreatitis, in 4 of 200 (2.0%) patients with sporadic pancreatic adenocarcinoma, in 0 of 36 (0%) of patients with familial pancreatic cancer and in 3 of 177 (1.7%) controls of chronic cholecystitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614554.RASFt-LB84fba1k8JlGOio9gAkR8ANUhqYxDAB07rCDbM130_provenance.
- NP755586.RAbKbo5gxjUEuxW5fOzTg0pWjLQi3fmZZgAO1Z8aGskBo130_assertion description "[The SPINK1 N34S polymorphism was detected in 5 of 172 (2.9%) patients with chronic pancreatitis, in 4 of 200 (2.0%) patients with sporadic pancreatic adenocarcinoma, in 0 of 36 (0%) of patients with familial pancreatic cancer and in 3 of 177 (1.7%) controls of chronic cholecystitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755586.RAbKbo5gxjUEuxW5fOzTg0pWjLQi3fmZZgAO1Z8aGskBo130_provenance.
- assertion description "[The SPINK1 N34S polymorphism was detected in 5 of 172 (2.9%) patients with chronic pancreatitis, in 4 of 200 (2.0%) patients with sporadic pancreatic adenocarcinoma, in 0 of 36 (0%) of patients with familial pancreatic cancer and in 3 of 177 (1.7%) controls of chronic cholecystitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The SPINK1 N34S polymorphism was detected in 5 of 172 (2.9%) patients with chronic pancreatitis, in 4 of 200 (2.0%) patients with sporadic pancreatic adenocarcinoma, in 0 of 36 (0%) of patients with familial pancreatic cancer and in 3 of 177 (1.7%) controls of chronic cholecystitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP862130.RAKWZmlIT8pEHwMmofLHrK8nw1ygoZrpOEvGqMGDE4bUU130_assertion description "[The SPINK1 N34S polymorphism was detected in 5 of 172 (2.9%) patients with chronic pancreatitis, in 4 of 200 (2.0%) patients with sporadic pancreatic adenocarcinoma, in 0 of 36 (0%) of patients with familial pancreatic cancer and in 3 of 177 (1.7%) controls of chronic cholecystitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862130.RAKWZmlIT8pEHwMmofLHrK8nw1ygoZrpOEvGqMGDE4bUU130_provenance.
- NP425562.RAcBdqKptlPKakQz3ECRu0OtWaendvyYwgDEYZ4R9dY3w130_assertion description "[The SPINK1 N34S polymorphism was detected in 5 of 172 (2.9%) patients with chronic pancreatitis, in 4 of 200 (2.0%) patients with sporadic pancreatic adenocarcinoma, in 0 of 36 (0%) of patients with familial pancreatic cancer and in 3 of 177 (1.7%) controls of chronic cholecystitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425562.RAcBdqKptlPKakQz3ECRu0OtWaendvyYwgDEYZ4R9dY3w130_provenance.
- NP710390.RApWE1qiB4hKUnhImUsLfMjMHBlPUH437L9ustz64zv5I130_assertion description "[The SPINK1 N34S polymorphism was detected in 5 of 172 (2.9%) patients with chronic pancreatitis, in 4 of 200 (2.0%) patients with sporadic pancreatic adenocarcinoma, in 0 of 36 (0%) of patients with familial pancreatic cancer and in 3 of 177 (1.7%) controls of chronic cholecystitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710390.RApWE1qiB4hKUnhImUsLfMjMHBlPUH437L9ustz64zv5I130_provenance.
- NP425550.RAg05Zj2XQYAaR6TBJvBfqhorJBpN1sEVRsc1NsqrAKY8130_assertion description "[The SPINK1 N34S polymorphism was detected in 5 of 172 (2.9%) patients with chronic pancreatitis, in 4 of 200 (2.0%) patients with sporadic pancreatic adenocarcinoma, in 0 of 36 (0%) of patients with familial pancreatic cancer and in 3 of 177 (1.7%) controls of chronic cholecystitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425550.RAg05Zj2XQYAaR6TBJvBfqhorJBpN1sEVRsc1NsqrAKY8130_provenance.